# HiComp Microtech(Suzhou)Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hicomp-microtech-suzhou-co

- Industry: Semiconductors
- Headquarters: Suzhou, China
- Website: www.hicompentest.creatby.com
- Total disclosed funding: $14M
- Latest round: Series B (Oct 14, 2022)
- Investors on record: 6

## About

Established in 2014 and based in Suzhou, China, HiComp Microtech(Suzhou)Co.,Ltd is a design manufacturer that engages in researching and developing components based on cutting-edge micro/nano technologies. The core research team has more than 50 employees. The company's R&D and production base located in Suzhou and cover more than 10000 square meters.

It provides lab-on-a-chip solutions and related laboratory products for many fields, such as biopsy, organ chip and gene editing. Its services divide into microfluidic design and processing, customized processing of medical consumables and MEMS processing. MEMS processing includes optical MEMS production line, mask, photolithography, SU8 process and PDMS process. Microfluidic design and processing include chip design and manufacturing, common materials and processes, precision micro injection molding, chip bonding solutions, and fluid capsule encapsulation. The company also provides laboratory consumables products includes pipette tips, microplate series, PCR series, cell culture series, etc.

## Funding rounds

- Series B, Oct 14, 2022, $14M — Shunwei Capital, China Fortune-Tech Capital
- Series B, Feb 25, 2021 — Huatai Zijin Investment, GL Ventures
- Angel, Feb 15, 2017 — Milestone Asset Management, Wuhan Renfu Biomedical Industry Investment Fund Center

## Investors

- Milestone Asset Management — Angel
- Wuhan Renfu Biomedical Industry Investment Fund Center — Angel
- Huatai Zijin Investment (https://capitalatlas.ai/funds/huatai-zijin-investment) — Series B
- GL Ventures (https://capitalatlas.ai/funds/gl-ventures) — Series B
- Shunwei Capital (https://capitalatlas.ai/funds/shunwei-capital) — Series B
- China Fortune-Tech Capital (https://capitalatlas.ai/funds/china-fortune-tech-capital) — Series B